FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092830544> ?p ?o ?g. }

• W3092830544 endingPage "e0240374" @default.
• W3092830544 startingPage "e0240374" @default.
• W3092830544 abstract "Background Chronic pulmonary aspergillosis (CPA) requires prolonged treatment with itraconazole or voriconazole. However, adverse events (AEs) are common with the use of these agents, with the need to discontinue the offending drug in a significant proportion of the patients. The aim of this study was to evaluate the frequency of adverse events of itraconazole and voriconazole for the treatment of CPA. Methods We searched Embase and Medline to select clinical studies providing information on AEs to itraconazole or voriconazole for the treatment of CPA from inception to May 2020. Reviews, single case reports, and case series reporting less than 10 patients were excluded. Random effect meta-analysis was performed using STATA 16.0. Results We included 9 eligible studies with an overall total of 534 CPA patients enrolled. Of these, 69% (n = 366) were treated with voriconazole and 31% (n = 168) with itraconazole. The median daily dose of both itraconazole and voriconazole used was 400mg. In a pooled analysis, AEs were observed in 36% (95% CI: 20–52%, N = 366) of patients on voriconazole and 25% (95% CI: 18 to 31%, N = 168) in those treated with itraconazole. Discontinuation rate due to AEs was the same for both drugs; 35% (47/366) and 35% (15/168) for voriconazole and itraconazole, respectively. There were 70 AEs reported with itraconazole use, the commonest being cardiotoxicity (29%). Skin AEs (28%) were the most frequent among the 204 AEs reported with voriconazole use. None of the studies compared the tolerability of itraconazole head-to-head with voriconazole. Conclusions AEs due itraconazole and voriconazole are common and may lead to discontinuation of treatment in a significant proportion of patients. This information can be used to educate patients prior to commencement of these antifungal therapies. PROSPERO registration number CRD42020191627" @default.
• W3092830544 created "2020-10-22" @default.
• W3092830544 creator A5001139059 @default.
• W3092830544 creator A5002682699 @default.
• W3092830544 creator A5014635530 @default.
• W3092830544 creator A5028018224 @default.
• W3092830544 creator A5058486560 @default.
• W3092830544 date "2020-10-14" @default.
• W3092830544 modified "2023-10-10" @default.
• W3092830544 title "Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis" @default.
• W3092830544 cites W1964720826 @default.
• W3092830544 cites W1991666307 @default.
• W3092830544 cites W1992757075 @default.
• W3092830544 cites W1999678851 @default.
• W3092830544 cites W2012447490 @default.
• W3092830544 cites W2012670747 @default.
• W3092830544 cites W2016110110 @default.
• W3092830544 cites W2019694314 @default.
• W3092830544 cites W2043053327 @default.
• W3092830544 cites W2068927932 @default.
• W3092830544 cites W2103962177 @default.
• W3092830544 cites W2114301066 @default.
• W3092830544 cites W2133564174 @default.
• W3092830544 cites W2135215253 @default.
• W3092830544 cites W2137341230 @default.
• W3092830544 cites W2144901153 @default.
• W3092830544 cites W2151225364 @default.
• W3092830544 cites W2152615086 @default.
• W3092830544 cites W2167539485 @default.
• W3092830544 cites W2168611326 @default.
• W3092830544 cites W2261914993 @default.
• W3092830544 cites W2565643097 @default.
• W3092830544 cites W2770352499 @default.
• W3092830544 cites W2797447443 @default.
• W3092830544 cites W2808421723 @default.
• W3092830544 cites W2852870824 @default.
• W3092830544 cites W2905787635 @default.
• W3092830544 cites W3000211548 @default.
• W3092830544 cites W4294215472 @default.
• W3092830544 doi "https://doi.org/10.1371/journal.pone.0240374" @default.
• W3092830544 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7556473" @default.
• W3092830544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33052954" @default.
• W3092830544 hasPublicationYear "2020" @default.
• W3092830544 type Work @default.
• W3092830544 sameAs 3092830544 @default.
• W3092830544 citedByCount "9" @default.
• W3092830544 countsByYear W30928305442021 @default.
• W3092830544 countsByYear W30928305442022 @default.
• W3092830544 countsByYear W30928305442023 @default.
• W3092830544 crossrefType "journal-article" @default.
• W3092830544 hasAuthorship W3092830544A5001139059 @default.
• W3092830544 hasAuthorship W3092830544A5002682699 @default.
• W3092830544 hasAuthorship W3092830544A5014635530 @default.
• W3092830544 hasAuthorship W3092830544A5028018224 @default.
• W3092830544 hasAuthorship W3092830544A5058486560 @default.
• W3092830544 hasBestOaLocation W30928305441 @default.
• W3092830544 hasConcept C126322002 @default.
• W3092830544 hasConcept C16005928 @default.
• W3092830544 hasConcept C197934379 @default.
• W3092830544 hasConcept C203014093 @default.
• W3092830544 hasConcept C2776391196 @default.
• W3092830544 hasConcept C2777071850 @default.
• W3092830544 hasConcept C2778375690 @default.
• W3092830544 hasConcept C2778715236 @default.
• W3092830544 hasConcept C2779548794 @default.
• W3092830544 hasConcept C2780690907 @default.
• W3092830544 hasConcept C71924100 @default.
• W3092830544 hasConceptScore W3092830544C126322002 @default.
• W3092830544 hasConceptScore W3092830544C16005928 @default.
• W3092830544 hasConceptScore W3092830544C197934379 @default.
• W3092830544 hasConceptScore W3092830544C203014093 @default.
• W3092830544 hasConceptScore W3092830544C2776391196 @default.
• W3092830544 hasConceptScore W3092830544C2777071850 @default.
• W3092830544 hasConceptScore W3092830544C2778375690 @default.
• W3092830544 hasConceptScore W3092830544C2778715236 @default.
• W3092830544 hasConceptScore W3092830544C2779548794 @default.
• W3092830544 hasConceptScore W3092830544C2780690907 @default.
• W3092830544 hasConceptScore W3092830544C71924100 @default.
• W3092830544 hasIssue "10" @default.
• W3092830544 hasLocation W30928305441 @default.
• W3092830544 hasLocation W30928305442 @default.
• W3092830544 hasOpenAccess W3092830544 @default.
• W3092830544 hasPrimaryLocation W30928305441 @default.
• W3092830544 hasRelatedWork W1992995916 @default.
• W3092830544 hasRelatedWork W1997483245 @default.
• W3092830544 hasRelatedWork W2008112150 @default.
• W3092830544 hasRelatedWork W2067219944 @default.
• W3092830544 hasRelatedWork W2134577373 @default.
• W3092830544 hasRelatedWork W2171990805 @default.
• W3092830544 hasRelatedWork W2401094395 @default.
• W3092830544 hasRelatedWork W2416781282 @default.
• W3092830544 hasRelatedWork W2484496567 @default.
• W3092830544 hasRelatedWork W856241021 @default.
• W3092830544 hasVolume "15" @default.
• W3092830544 isParatext "false" @default.
• W3092830544 isRetracted "false" @default.
• W3092830544 magId "3092830544" @default.
• W3092830544 workType "article" @default.